Mycrodose Therapeutics
PrivateLast Round
Seed
Sep 21, 2021
Company Overview
Mycrodose Therapeutics is a pharmaceutical company that develops advanced drug delivery systems utilizing psychedelic compounds to treat mental health and cognitive degenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mycrodose Therapeutics Comparables
Compare Mycrodose Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Psycheceutical Bioscience, Inc. | 88% | |
| Bexson Biomedical | 76% | |
| Biotts | 72% |
Mycrodose Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 21, 2021 |
Mycrodose Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Supernode Ventures | Seed |
| Negev Capital | Seed |
| The Conscious Fund | Seed |
| K2 & Associates | Seed |
| Ambria Capital | Seed |
| XEIA Venture Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 21, 2021
Raised a Seed round with participation from K2 & Associates and Ambria Capital.
Mycrodose Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mycrodose Therapeutics's valuation, stock price, and market status.
Is Mycrodose Therapeutics a public or private company?
Mycrodose Therapeutics is a private company.
What is the current stock price of Mycrodose Therapeutics?
Mycrodose Therapeutics is a private company with no public stock price. Caplight tracks Mycrodose Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Mycrodose Therapeutics worth (valuation)?
Valuation information for Mycrodose Therapeutics is not publicly available.
Can I buy Mycrodose Therapeutics stock?
Mycrodose Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Mycrodose Therapeutics's last funding round?
Mycrodose Therapeutics's most recent funding round was Seed on September 21, 2021.
Who are the main investors in Mycrodose Therapeutics?
Key investors in Mycrodose Therapeutics include Supernode Ventures, Negev Capital, The Conscious Fund, K2 & Associates, Ambria Capital.
Will Mycrodose Therapeutics IPO soon?
No public IPO plans have been announced for Mycrodose Therapeutics.
How can I track Mycrodose Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mycrodose Therapeutics's secondary market activity and sign up for updates.